Xiamen Amoytop Biotech Co. Ltd Financials

Market Capitalization CN¥28.67 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	38.73
Forward PE	25.35
Price to Sales TTM	CN¥11.05
Price to Book MRQ	CN¥12.66
Enterprise to Revenue	10.65
Enterprise to EBITDA	30.34

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	28.54%
Operating Margin	38.65%
Return on Assets TTM	22.10%
Return on Equity TTM	37.46%

Income Statement

Revenue TTM	CN¥2,595,233,792
Revenue per Share TTM	CN¥6.38
Quarterly Revenue Growth	37.50%
Gross Profit TTM	CN¥1,960,268,519
EBITDA	CN¥850,032,694
Net Income to Common TTM	CN¥740,692,288
Diluted EPS TTM	CN¥1.82
Quarterly Earnings Growth YoY	49.80%

Balance Sheet

Total Cash MRQ	CN¥584,547,904
Total Cash per Share MRQ	CN¥1.44
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.44
Current Ratio MRQ	4.32
Book Value per Share MRQ	CN¥5.57

Cash Flow

Operating Cash Flow TTM	CN¥421,164,160
Levered Free Cash Flow TTM	CN¥-78,039,168

688278 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	406,800,000
Float Shares	110,495,016
Avg 10 Volume	3,150,856
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	68.40%
% Held by Institutions	16.61%

Stock Price Summary

Beta	0.43
Fifty Two Week Low	CN¥46.30
Fifty Two Week High	CN¥86.11
Fifty Two Week Change	35.20%
Day 50 MA	CN¥76.07
Day 200 MA	CN¥62.15

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.64
Forward Annual Dividend Yield	2.05%
Trailing Annual Dividend Rate	CN¥0.41
Trailing Annual Dividend Yield	0.51%
Payout Ratio	22.53%
Dividend Date
Ex Dividend Date	2024-05-23
Last Split Factor
Last Split Date